Skip to content

Corposano: what changed

BE 0732.556.173NACE 86.210, General medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€103,791
2024 · €110,198-€6,407
Equity
€141,489
2024 · €274,379-€132,890
Cash
€81,241
2024 · €235,555-€154,314
Balance sheet total
€153,639
2024 · €281,384-€127,745

Largest movements

2024 to 2025
Assets
  • Cash -€154,314

    down €154,314 (-65.5%), from €235,555 to €81,241

    mainly Contributions, distributions and other (-€236,681) and Current investments (-€23,000)

  • Current investments +€23,000

    up €23,000 (+153%), from €15,000 to €38,000

  • Receivables within one year +€10,806

    up €10,806 (+55.4%), from €19,492 to €30,298

  • Deferred charges and accrued income -€9,380

    no longer reported in 2025; in 2024 it stood at €9,380

Equity and liabilities
  • Profit (loss) carried forward -€132,890

    down €132,890 (-49.8%), from €266,879 to €133,989

  • Current portion of long-term debt +€10,000

    first reported in 2025, at €10,000

  • Tax, wage and social debts -€5,532

    down €5,532 (-86.8%), from €6,372 to €840

    of which Remuneration and social security: -€5,400

Income statement
  • Gross operating margin -€6,613

    down €6,613 (-4.6%), from €142,699 to €136,086

  • Financial income -€1,808

    down €1,808 (-82.2%), from €2,199 to €391

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €110,198
Gross operating margin -€6,613
Depreciation +€1,355
Other operating charges -€72
Financial income -€1,808
Financial charges -€372
Taxes +€1,103
Result 2025 €103,791
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€99,068
Investment -€26,701
Financing -€226,681
Cash 2024 €235,555
Net result for the year +€103,791
Depreciation +€1,558
Receivables within one year -€10,806
Deferred charges and accrued income +€9,380
Smaller working-capital items +€677
Tax, wage and social debts -€5,532
Investment in fixed assets (net) -€3,701
Current investments -€23,000
Current portion of long-term debt +€10,000
Contributions, distributions and other -€236,681
Cash 2025 €81,241
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €281,384 €153,639 -€127,745 -45.4%
Fixed assets 21/28 €1,957 €4,100 +€2,143 +110%
Tangible fixed assets 22/27 €1,957 €4,100 +€2,143 +110%
Plant, machinery and equipment 23 €1,455 €811 -€644 -44.3%
Furniture and vehicles 24 €502 €3,289 +€2,787 +555%
Current assets 29/58 €279,427 €149,539 -€129,888 -46.5%
Amounts receivable within one year 40/41 €19,492 €30,298 +€10,806 +55.4%
Other amounts receivable 41 €19,492 €30,298 +€10,806 +55.4%
Current investments 50/53 €15,000 €38,000 +€23,000 +153%
Cash at bank and in hand 54/58 €235,555 €81,241 -€154,314 -65.5%
Deferred charges and accrued income 490/1 €9,380 - -€9,380
Total equity and liabilities 10/49 €281,384 €153,639 -€127,745 -45.4%
Equity 10/15 €274,379 €141,489 -€132,890 -48.4%
Contributions 10/11 €7,500 €7,500 = 0.0%
Profit (loss) carried forward 14 €266,879 €133,989 -€132,890 -49.8%
Amounts payable 17/49 €7,005 €12,150 +€5,145 +73.4%
Amounts payable within one year 42/48 €7,005 €11,748 +€4,743 +67.7%
Current portion of amounts payable after more than one year 42 - €10,000 +€10,000
Trade debts 44 €633 €908 +€275 +43.4%
Suppliers 440/4 €633 €908 +€275 +43.4%
Taxes, remuneration and social security 45 €6,372 €840 -€5,532 -86.8%
Taxes 450/3 €972 €840 -€132 -13.6%
Remuneration and social security 454/9 €5,400 - -€5,400
Accrued charges and deferred income 492/3 - €402 +€402
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,913 €1,558 -€1,355 -46.5%
Other operating charges 640/8 €700 €772 +€72 +10.3%
Gross operating margin 9900 €142,699 €136,086 -€6,613 -4.6%
Operating profit (loss) 9901 €139,086 €133,756 -€5,330 -3.8%
Financial income 75/76B €2,199 €391 -€1,808 -82.2%
Recurring financial income 75 €2,199 €391 -€1,808 -82.2%
Financial charges 65/66B €115 €487 +€372 +323%
Recurring financial charges 65 €115 €487 +€372 +323%
Profit (loss) for the period before taxes 9903 €141,170 €133,660 -€7,510 -5.3%
Income taxes 67/77 €30,972 €29,869 -€1,103 -3.6%
Profit (loss) for the period 9904 €110,198 €103,791 -€6,407 -5.8%
Profit (loss) for the period to be appropriated 9905 €110,198 €103,791 -€6,407 -5.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€446,309 to €596,534

Midpoint €508,903 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €141,489
Capitalised earnings €751,129 to €1.1m
Indication €446,309 to €596,534

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€141,489
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€141,489

Capitalised earnings

net result for the year (9904)
2025
€103,791
2024
€110,198
2023
€101,485
2022
€94,103
2021
€103,611
Average result
€105,158
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€751,129 / €876,317 / €1.1m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.